To explore the effect of fiberoptic bronchoscopy in the treatment of patients with severe pulmonary infection complicated with atelectasis.

A retrospective study of 72 patients with severe pulmonary infection and atelectasis admitted to the Third People’s Hospital of Xining City from March 2016 to March 2018 was conducted. According to the random number table method, they were divided into 2 groups, each with 36 cases. Thirty-six patients with severe pulmonary infection and atelectasis were treated as group A. On this basis, 36 patients with severe pulmonary infection complicated with atelectasis treated by fiberoptic bronchoscopy were used as group B. In group A, there were 27 males and 9 females; they were 44-65 years old, with an average age of (54.12 ± 19.57) years old. In group B, there were 26 males and 10 females; they were 45-64 years old, with an average age of (54.94±18.58) years. We observed and compared the blood gas analysis indexes of the two groups, PCT, CRP, plasma visfatin indexes, curative effect and clinical recovery time.

After treatment, the recovery time of each clinical symptom in group B was shorter than that in group A. After treatment in group B, PCT, CRP, and plasma visfatin were lower than those in group A, and SaO₂, PaO₂ and OI in group B were higher than those in group A. Lac was lower than that of group A (P<0.05).

For patients with severe pulmonary infection and atelectasis, fiberoptic bronchoscopy can be used to observe the patientcopy can monary infection and atelectasis, fiberoptic bronchoscopy can in group A. Lac to suck out the airway secretions as much as possible, so as to dredge the bronchus, improve the respiratory function of patients, and carry out pathogenic bacteria cultivation and drug sensitivity test, and further targeted application of antibiotics. Therefore, the effect is better than conventional treatment, and it can be promoted.